Incyte and Cancer Support Community Delaware Announce the Establishment of the Incyte Cancer Care Assistance Fund for Delaware
October 06 2017 - 9:00AM
Business Wire
Fund to provide emergency financial support for
Delaware cancer patients and their families
Incyte Corporation (Nasdaq:INCY) and Cancer Support Community
Delaware (CSCDE) today announced the establishment of the Incyte
Cancer Care Assistance Fund for Delaware which will provide
emergency financial assistance for cancer patients, their
caregivers and family members living in Delaware.
This press release features multimedia. View
the full release here:
http://www.businesswire.com/news/home/20171006005108/en/
Through the Incyte Charitable Giving Foundation, Incyte has
committed to providing a maximum of $100,000 each year to CSCDE
over the next 5 years, beginning in 2018.
“We are very pleased to announce the creation of the Incyte
Cancer Care Assistance Fund for Delaware with Cancer Support
Community Delaware, an organization which, like Incyte, is
dedicated to supporting patients with cancer and the local
community,” said Paula Swain, Executive Vice President of Human
Resources and Chair of The Incyte Charitable Giving Foundation.
“Today, as we celebrate the opening of our newly expanded
headquarters in Wilmington, we reaffirm our commitment to Delaware
and to the well-being of the communities we serve.”
The fund will be administered by Cancer Support Community
Delaware. Additional details about the Incyte Cancer Care
Assistance Fund for Delaware will be made available in January
2018.
“Through the establishment of this fund, we aim to address the
emergent needs that patients with cancer in Delaware face as they
navigate their disease and its impact across all aspects of their
lives,” said Nicole Topkis Pickles, Executive Director of Cancer
Support Community Delaware.
About Cancer Support Community Delaware
The mission of Cancer Support Community Delaware is to ensure
that all people impacted by cancer are empowered by knowledge,
strengthened by action and sustained by community. Through
participation in professionally led support groups, educational
workshops and mind/body classes, people affected by cancer learn
vital skills that enable them to regain control, reduce isolation
and restore hope regardless of the stage of disease. At Cancer
Support Community Delaware, all programs are at no cost to cancer
patients, caregivers and family members. More information about
Cancer Support Community Delaware is available at
www.cancersupportdelaware.org.
About the Incyte Charitable Giving Foundation
The Incyte Charitable Giving Foundation, part of Incyte
Involved, the Company’s philanthropic and employee and community
engagement program, provides charitable donations to publicly
funded 501(c) (3) tax-exempt nonprofit organizations specifically
serving the needs of communities in Delaware focused on two
areas—Oncology Patient Support and Resources and Community
Partnerships.
More information regarding Incyte Involved and the Incyte
Charitable Giving Foundation, including the application process,
funding guidelines, important information for applicants and
quarterly submissions calendar, can be found here.
About Incyte
Incyte Corporation is a Wilmington, Delaware-based
biopharmaceutical company focused on the discovery, development and
commercialization of proprietary therapeutics. For additional
information on Incyte, please visit the Company’s website. Follow
@Incyte on Twitter.
Forward-Looking Statements
Except for the historical information set forth herein, the
matters set forth in this press release, including statements
regarding the expectations for, and the focus of, the Incyte
Charitable Giving Foundation, contain predictions, estimates and
other forward-looking statements. These forward-looking statements
are based on the Company’s current expectations and subject to
risks and uncertainties that may cause actual results to differ
materially, including, without limitation those risks detailed from
time to time in the Incyte’s reports filed with the Securities and
Exchange Commission, including its Form 10-Q for the quarter ended
June 30, 2017. Incyte disclaims any intent or obligation to update
these forward-looking statements.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171006005108/en/
Incyte CorporationMediaCatalina Loveman, +1
302-498-6171cloveman@incyte.comorInvestorsMichael Booth,
DPhil, +1 302-498-5914mbooth@incyte.com
Incyte (NASDAQ:INCY)
Historical Stock Chart
From Aug 2024 to Sep 2024
Incyte (NASDAQ:INCY)
Historical Stock Chart
From Sep 2023 to Sep 2024